Exabis Library
Welcome to the e-CCO Library!
DOP028: Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP029: Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post-hoc analysis of the taxit trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP029: Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: Post-hoc analysis of the taxit trial
2017
ECCO'17 Barcelona
1
DOP029: Outcomes of a managed switching program changing IBD patients established on originator infliximab to biosimilar infliximab
2016
ECCO'16 DOP
1
DOP029: Outcomes of a managed switching programme changing IBD patients established on originator infliximab to biosimilar infliximab
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP029: Treatment and long-term outcomes of paediatric patients with penetrating Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP029: Treatment and long-term outcomes of paediatric patients with penetrating Crohn’s Disease
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP02: Developing explicit thresholds for outcomes to inform (GRADE) Evidence to Decision frameworks for Inflammatory Bowel Disease guidelines.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP02: Increasing incidence of Inflammatory Bowel Disease in a high prevalence country: A nationwide study in Finland
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP02: Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel Diseases
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP02: Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel Diseases
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP02: Supplementation with butyrate producing bacteria reduces tumor load in a mouse model of colitis associated cancer
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP02: Supplementation with butyrate producing bacteria reduces tumour load in a mouse model of colitis-associated cancer
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP02: The dose-dependent effect of enteral nutrition on faecal microbial metabolites of healthy volunteers
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP02: The dose-dependent effect of enteral nutrition on faecal microbial metabolites of healthy volunteers
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP02: αEβ7 positive γδ T cells are associated with mucosal healing in Ulcerative Colitis and have a homeostatic immunophenotype
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP03 The impact of elemental diet on the human gut microbial structure and intestinal metabolites
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP030: Anti-TNF re-induction is as effective, simpler and cheaper compared with dose interval shortening following secondary loss of response in Crohn's disease: a dual centre “real world” study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP030: Anti-TNF re-induction is as effective, simpler and cheaper compared with dose interval shortening following secondary loss of response in Crohn’s Disease: A dual centre ‘real world’ study
2017
ECCO'17 Barcelona
1
DOP030: Elective switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: a prospective observational cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM